Ovarian failure
Information
- Disease name
- Ovarian failure
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04444245 | Active, not recruiting | Phase 1 | Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF | July 15, 2022 | August 15, 2025 |
NCT03040921 | Completed | N/A | Uterine Transposition: Feasibility Study | June 1, 2017 | April 1, 2021 |
NCT03398603 | Completed | Is the Concentration of Anti-Muellerian Hormon (AMH) Depending on the Menstrual Cycle? | November 1, 2016 | October 13, 2019 | |
NCT01197456 | Completed | Predictors of Ovarian Insufficiency in Young Breast Cancer Patients | September 24, 2008 | July 18, 2019 | |
NCT03907618 | Completed | Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes | July 1, 2018 | January 1, 2019 | |
NCT04024449 | Completed | Can Celiac Disease Affect Ovarian Function in Adolescent? | January 1, 2017 | May 31, 2018 | |
NCT04163640 | Completed | N/A | Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response | February 24, 2020 | July 21, 2023 |
NCT04776902 | Completed | N/A | Effects of Ovarian Reserve on Sexual Satisfaction | October 1, 2020 | June 1, 2021 |
NCT06394466 | Completed | Thyroid Function and Autoimmunity in Subfertility Women and Assisted Reproductive Therapy | July 1, 2021 | July 31, 2023 | |
NCT06426771 | Not yet recruiting | Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density | June 1, 2024 | October 1, 2024 | |
NCT04275700 | Recruiting | N/A | Study of PRP in Women With Evidence of Diminished Ovarian Reserve | October 1, 2018 | September 1, 2024 |
NCT05181748 | Recruiting | Phase 2/Phase 3 | Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders | January 23, 2019 | January 31, 2026 |
NCT05158933 | Recruiting | Phase 1 | Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure | December 2022 | January 2026 |
NCT03475758 | Unknown status | Phase 2 | Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide | March 2018 | March 2020 |
NCT03674164 | Unknown status | N/A | Fertility Preservation With Ovarian Tissue Freezing | September 10, 2019 | December 31, 2023 |
NCT04306185 | Unknown status | N/A | Ovarian Fragmentation Study (Crespo Medical Team) | May 1, 2020 | March 1, 2021 |
NCT04009473 | Unknown status | Phase 1/Phase 2 | Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation | June 1, 2019 | December 2021 |
NCT02280681 | Unknown status | MAR With Artificial Gametes: Treatment Characteristics and Their Trade-offs Determining Treatment Preference | October 2014 | October 2015 |
- MedGen concept unique identifier (MedGen Concept name)
- C0747102
- MedGen unique identifier (MedGen Concept name)
- 677092